Press Releases

Bio-Gate signs cooperation agreement with Aesculap AG for coating revision implants

Accumen Launches National Health System Crisis Readiness Survey to Provide Benchmarks and Insights to U.S. Hospitals

Survey will gather data from hospital laboratory, blood management, imaging, and data departments across the nation 

CD Genomics Upgrades Highly Accurate Single-Cell Sequencing Services for Researchers

Creative Enzymes Launches Enzymes for Coronavirus Nucleic Acid Test to Help the Detection of COVID-19

Creative Proteomics Launches Several Newly-developed Services for Protein Related Projects

Broad-spectrum Antiviral Drug Discovery Services Are Ready to Facilitate SARS-CoV-2 Research

Creative Biolabs has combined with integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in SARS-CoV-2 candidates screening, effective viral inhibitors discovery, therapeutic antibody development and vaccine exploration.

Absolute Antibody and University of Zurich Collaborate to Offer Synthetic Nanobodies Against SARS-CoV-2 Receptor Binding Domain

Creative Bioarray Unveils Comprehensive Histology Services to Accelerate the Projects in Biolinical Research

Creative Biogene CRISPR: Offering Solutions for Gene Research with Various Genome Editing Services

CD Genomics Releases Kits and Reagents for Coronavirus Research to Aid in COVID-19 Response

Creative BioMart Enlarged Its Metabolism Proteins List

Profacgen Provides Pharmacophore Modeling for Drug Design

Creative Biostructure Updated Its Membrane Protein Service

Lifeasible Updated Its Physical Purity Testing Service for Seed Testing

Matexcel Updated Its Customized Polymerization Service

Customized Biodegradable Polymers Are Available at CD Bioparticles

Empowered by leading technology and years of experience in drug delivery, CD Bioparticles now integrate various kinds of biodegradable polymers into its all-inclusive array of products covering lipids, liposomes, biopolymers and synthetic polymers.

Creative Bioarray Unveils Comprehensive Histology Services to Accelerate The Projetcs in Biolinical Research

VERICHEM LABORATORIES OFFERS MULTI-ANALYTE, BIO-SYNTHETIC, NIST TRACEABLE, URINE CHEMISTRIES STANDARDS KIT

VERICHEM LABORATORIES offers a ready-to-use, NIST traceable, multianalyte, bio-synthetic standard reference kit for urine chemistry assays intended for the calibration, or calibration verification, of urine chemistry assays on a wide variety of “wet” clinical testing systems.

Shimmer Named 2020 Citeline Award Finalist for Its Verisense™ Continuous Monitoring Platform for Clinical Trials; Co-founding Open Wearables Initiative

Shimmer’s Verisense platform reliably captures accurate and complete biometric data, while placing minimum burden on clinical trial sponsors, sites and participants. The Open Wearables Initiative (www.OWEAR.org) is an industry collaboration designed to promote the effective use of high-quality, sensor-generated measures of health in clinical research through the open sharing of algorithms and datasets.

Abingdon Health announces its latest expansion and additional manufacturing capacity

Abingdon Health is pleased to announce further expansion at its York headquarters in the UK, following further investment in state-of-the-art lateral flow automation. This will provide a significant increase in its manufacturing footprint, resulting in Europe’s largest capacity for rapid test manufacturing. This news comes weeks after the UK Government announced Abingdon Health as one of the leading members of the UK Rapid Test Consortium (UK-RTC).